Return on Sales by Net Profit: Aadi Bioscience Inc (WHWK)

Graphic logo of Aadi Bioscience, Inc. (WHWK)

Aadi Bioscience Inc (WHWK) is scaling the distribution of oncology drugs while optimizing R&D costs. GURU.Markets analytics provides this chart, where the net profit margin demonstrates local dynamics and the value of 0.00 serves as the current metric. Revenues are based on the sale of FYARRO for the treatment of rare tumors. An engineering approach to developing albumin-based drug delivery systems significantly enhances therapy precision.

aadibio.com (WHWK) - Net Margin from 03/20/2025 to 11/19/2026

Analytical breakdowns for Aadi Bioscience Inc

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:aadibio.com - WHWK
Manufactured product of aadibio.com

Aadi Bioscience Inc (WHWK) specializes in the development of niche oncological drugs. The net profit margin determines the portion of revenue remaining after deducting all operating and tax expenses. This indicator measures the actual efficiency of intellectual property monetization. For a company dependent on the success of a few products, any decline in the net profit margin signals licensing risks. This daily chart eliminates reporting time lags, providing an accurate valuation of capital.

Main competitors

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|TCRX (TScan Therapeutics, Inc.) - Return on Sales by Net Profit|Net Margin Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Net Sales Margin|CVM (CEL-SCI Corporation) - Company Net Profitability|Net Sales Margin OSTX|Net Sales Margin Radiopharm Theranostics Ltd (RADX)|Net Sales Margin ARTV (Artiva Biotherapeutics)|Net Sales Margin Adlai Nortye Ltd. ANL|Veru Inc - Net Sales Margin|Company Sales Margin Tempest Therapeutics TPST|XLO: Net Sales Margin|Enochian BioSciences (RENB) - Net Sales Margin|Return on Sales by Net Profit MURA|Kairos Pharma Ltd - Net Profit Margin|Net Sales Margin OKUR|CytoMed Therapeutics Limited (GDTC) - Net Profitability Margin|Net Sales Margin CRIS (Curis, Inc.)|APLM: Net Return on Sales|Tharimmune Corporation - Net Sales Margin|ADVB: Net Margin|GNPX: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)